Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Frazier Life Sciences XI, L.P. | 10% Owner | Buy (P) | 588K | $10.0M |
| Aug 6, 2026 | Sanofi | 10% Owner | Buy (P) | 300K | $5.1M |
| Aug 6, 2026 | Redmile Group, LLC | 10% Owner | Buy (P) | 200K | $3.4M |
| Aug 6, 2026 | Redmile Group, LLC | 10% Owner | Buy (P) | 400K | $6.8M |
| Aug 6, 2026 | venBio Global Strategic Fund IV, L.P. | 10% Owner | Buy (P) | 382K | $6.5M |
| Aug 6, 2026 | WALSH COLIN | Director | Buy (P) | 500K | $8.5M |
| Aug 6, 2026 | GOLDMAN SACHS GROUP INC | Insider | Buy (P) | 500K | $8.5M |
| Aug 5, 2026 | WALSH COLIN | Director | Buy (P) | 85K | $1.8M |
| Aug 5, 2026 | WALSH COLIN | Director | Sell (S) | 988 | $22K |
| Aug 5, 2026 | WALSH COLIN | Director | Sell (S) | 447 | $10K |
| Aug 5, 2026 | WALSH COLIN | Director | Sell (S) | 1K | $29K |
| Aug 5, 2026 | WALSH COLIN | Director | Sell (S) | 200 | $4K |
Connected entities for Attovia Therapeutics, Inc.
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ATTO/capital-change-brief"
Use Arkolith's capital_change_brief for Attovia Therapeutics, Inc.. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ATTO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.